These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1649037)
41. Differential modulation of integrin receptors and extracellular matrix laminin by transforming growth factor-beta 1 in rat alveolar epithelial cells. Kumar NM; Sigurdson SL; Sheppard D; Lwebuga-Mukasa JS Exp Cell Res; 1995 Dec; 221(2):385-94. PubMed ID: 7493638 [TBL] [Abstract][Full Text] [Related]
42. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf. Huggett AC; Hampton LL; Ford CP; Wirth PJ; Thorgeirsson SS Cancer Res; 1990 Dec; 50(23):7468-75. PubMed ID: 2174726 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of transforming growth factor-beta 1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: implications for endometriosis and peritoneal adhesion formation. Dou Q; Williams RS; Chegini N Mol Hum Reprod; 1997 May; 3(5):383-91. PubMed ID: 9239722 [TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. Brennan TJ; Edmondson DG; Li L; Olson EN Proc Natl Acad Sci U S A; 1991 May; 88(9):3822-6. PubMed ID: 1850837 [TBL] [Abstract][Full Text] [Related]
45. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Sassoon D; Lyons G; Wright WE; Lin V; Lassar A; Weintraub H; Buckingham M Nature; 1989 Sep; 341(6240):303-7. PubMed ID: 2552320 [TBL] [Abstract][Full Text] [Related]
46. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123 [TBL] [Abstract][Full Text] [Related]
50. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases. Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741 [TBL] [Abstract][Full Text] [Related]
51. Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryo. Hannon K; Smith CK; Bales KR; Santerre RF Dev Biol; 1992 May; 151(1):137-44. PubMed ID: 1374351 [TBL] [Abstract][Full Text] [Related]
52. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Arvanitakis L; Yaseen N; Sharma S J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179 [TBL] [Abstract][Full Text] [Related]
53. Induced expression of myoD, myogenin and desmin during myoblast differentiation in embryonic mouse tongue development. Yamane A; Takahashi K; Mayo M; Vo H; Shum L; Zeichner-David M; Slavkin HC Arch Oral Biol; 1998 May; 43(5):407-16. PubMed ID: 9681116 [TBL] [Abstract][Full Text] [Related]
54. Regulation of myogenic differentiation by type beta transforming growth factor. Olson EN; Sternberg E; Hu JS; Spizz G; Wilcox C J Cell Biol; 1986 Nov; 103(5):1799-805. PubMed ID: 3465734 [TBL] [Abstract][Full Text] [Related]
55. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. Zhang H; Shaw AR; Mak A; Letarte M J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807 [TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-β signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis. Jaffe M; Sesti C; Washington IM; Du L; Dronadula N; Chin MT; Stolz DB; Davis EC; Dichek DA Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):e1-11. PubMed ID: 21979435 [TBL] [Abstract][Full Text] [Related]
57. A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. Fafeur V; O'Hara B; Böhlen P Mol Biol Cell; 1993 Feb; 4(2):135-44. PubMed ID: 8382975 [TBL] [Abstract][Full Text] [Related]
58. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors. Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308 [TBL] [Abstract][Full Text] [Related]
59. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development. Haider SR; Wang W; Kaufman SJ Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852 [TBL] [Abstract][Full Text] [Related]
60. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]